Scotiabank lowered the firm’s price target on Methanex (MEOH) to $48 from $50 and keeps an Outperform rating on the shares. Following Q3 results, Methanex remains a top pick for Scotiabank under its Chemicals coverage, the analyst tells investors. The firm lowered its price target on the stock due to low Q3 EBITDA moving B/S leverage “in the wrong direction.”
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MEOH:
- Methanex Earnings Call: Integration Success Amid Market Challenges
- Positive Outlook for Methanex: Buy Rating Backed by Strong Operations and Strategic Initiatives
- Methanex upgraded to Overweight from Neutral at JPMorgan
- Methanex Reports Q3 2025 Results Amid Production Boost
- Methanex Reports Q3 2025 Results with Increased Production and Strategic Financial Moves
